Flomoxef, formerly known as S 6315, is an oxacephem antibiotic. Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections. he MICs of flomoxef at which 90% of clinical isolates were inhibited was >128 microg/mL in 26 isolates of Mycobacterium abscessus and 4 microg/mL in 31 isolates of M. fortuitum. Three out of 4 clinical M. peregrinum isolates were inhibited by flomoxef at concentrations of 4 microg/mL or less. References: Lee CH, Chen IL, Li CC, Chien CC. Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia. Infect Drug Resist. 2018 Feb 23;1257-266. doi: 10.2147/IDR.S146923. eCollection 2018. PubMed PMID: 29503575; PubMed Central PMCID: PMC5826091.

纯度：≥98%

CAS：92823-03-5